Clinical Trials Browser

Phase 3 × Carcinoid Tumor × Clear all

NCT07087054 2026-04-30

CAREFNDR

Phase 3 Recruiting

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05477576 2026-03-30

ACTION-1

Phase 3 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT00227136 2018-04-13

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Phase 3 Terminated

Carcinoid Tumor, Neuroendocrine Tumors

NCT00412061 2014-11-21

RADIANT-2

Phase 3 Completed

429 enrolled 13 charts

Carcinoid Tumor, Carcinoma, Malignant Carcinoid Syndrome, Neoplasms

NCT00690430 2013-07-30

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Phase 3 Completed

186 enrolled 11 charts

Carcinoid Tumor

NCT01373736 2011-06-15

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Phase 3 Unknown

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Pheochromocytoma, Carcinoma, Medullary